• BG IRIS Research Client Login
logo
  • Home
  • Services
    • Investment Banking
      • Our transactions
      • Private Placements
      • Public Offerings
      • M&A for private companies
      • M&A for public companies
    • Capital Markets
      • Institutional Sales
      • Derivatives Sales & Trading
    • Research
      • Equity Research
      • Corporate Research
      • Equity Research login
    • Sectors
      • Healthcare
      • Software
      • Energy Transition & Sustainability
      • Industrial Tech
      • NextGen Consumer
      • Business & Tech-enabled Services
  • Company news
  • BG IRIS
  • Events
  • About us
    • Senior Team
    • About us
    • Contact Us
  • Careers
    • Our vacancies
    • Our Investment Banking Positions
    • Current Equity Sales & Research Positions
    • Current Support Team Offerings
    • Current Internship Offerings
  • 25 YEARS
  • Search
  • BG IRIS Research Client Login

ECM

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Medincell's EUR 25 million Follow-on Offering

Bryan, Garnier & Co acts as Financial Advisor & Placement Agent on Abivax’s EUR 130 million Cross-over Financing

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on a €20m secondary offering of HRS shares

Bryan, Garnier & Co acts as Sole Financial Advisor to Selfapy, one of the leading providers in digital therapeutics for mental health disorders in Germany, on its growth financing from strategic investor Medice Arzneimittel and existing shareholders

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Egetis Therapeutics' Nasdaq Stockholm SEK 210 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Bookrunner on Oncodesign Precision Medicine's EUR 8 million Follow-on Offering & IPO on Euronext Growth Paris

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Nicox' Euronext Paris EUR 10 million Follow-on Offering & Warrants issuance

Bryan, Garnier & Co acts as Joint Bookrunner on Valneva’s Nasdaq and Euronext Paris EUR 102.9 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Global Coordinator and Joint Bookrunner on Abivax’s EUR 49 million Cross-over Financing

Bryan Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Lhyfe on its landmark €110m IPO on Euronext Paris

  • 1
  • 2
  • 3
  • …
  • 13
Menu

Home

All transactions

Investment Banking

Capital Markets

Sectors

Our Insights

Other

Events

Our team

Careers

About us

Press

Contact us

Legal

  • Legal Information
  • Index 2022
  • Bryan Garnier Securities
  • Privacy Policy

Latest News

  • Bryan Garnier Expands Software and Fintech Investment Banking team with new Managing Director
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
SAVE & ACCEPT

Privacy Preference Center

Privacy Preferences